Jefferies maintained a Hold rating on Myriad Genetics (NASDAQ: MYGN), and cut the price target to $20.00 (from $34.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Notable 52-Week Highs and Lows 8/10: (YELP) (REN) (HWAY) High; (SPWR) (MYGN) (MCHX) LowAugust 10, 2016 3:33 PM Unusual 11 Mid-Day Movers 8/10: (DXPE) (SENS) (HWAY) High; (MYGN) (SPWR) (WGBS) LowAugust 10, 2016 12:54 PM Pre-Open Stock Movers 08/10: (CLNE) (OCN) (HRTX) (YELP) Higher; (GEVO) (SPWR) (MYGN) (PRGO) Lower (more...)August 10, 2016 9:28 AM Gabelli Downgrades Myriad Genetics (MYGN) to HoldAugust 10, 2016 8:17 AM Barclays Downgrades Myriad Genetics (MYGN) to EqualweightAugust 10, 2016 7:40 AM Mizuho Securities Cuts Price Target on Myriad Genetics (MYGN) to $22 Following 4Q and Guidance August 10, 2016 7:19 AM Wells Fargo Downgrades Myriad Genetics (MYGN) to Market PerformAugust 10, 2016 7:03 AM Piper Jaffray Downgrades Myriad Genetics (MYGN) to NeutralAugust 10, 2016 6:38 AM After-Hours Stock Movers 08/09: (CLNE) (OCN) (YELP) Higher; (GEVO) (SPWR) (MYGN) Lower (more...)August 9, 2016 6:01 PM Myriad Genetics (MYGN) Misses Q4 EPS by 6c; Issues Weak Q1, FY17 OutlookAugust 9, 2016 4:11 PM Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial ResultsAugust 9, 2016 4:06 PM Myriad Genetics (MYGN) halted with news pendingAugust 9, 2016 4:00 PM